Siedlerstraße 7 | 68623 Lampertheim, Germany

info@zamann-pharma.com

Pfizer reported stronger-than-expected second-quarter results on August 4 in New York and added $2.5 billion to its cost-reduction plan. The company now expects $9.7 billion in net savings through 2029 while raising the midpoint of its 2026 revenue outlook. This
The FDA proposed a new registration pathway on July 10, 2026, for distributed manufacturing networks that operate through a hub-and-spoke model. If finalized, the FDA distributed manufacturing rule would let qualifying networks register as one establishment instead of registering every